NDC 59368-003 - up and up dye free infants concentrated ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-003
- Package NDCs from labels
- 59368-003-01, 59368-003-02
- Manufacturer
- Sixarp, LLC
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| up and up dye free infants concentrated ibuprofen - Sixarp, LLC | Sixarp, LLC | 2024-03-15 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | 24ef6819-f098-4d01-bfe7-6ffa4aa0e671 | 2019-12-10 | Warnings | WK2XYI10QM |
| Congestion Relief | IBUPROFEN, PHENYLEPHRINE HCL | Meijer Distribution Inc | 84f932b6-0aee-4cf9-b4b9-213560c42c1d | 2019-12-05 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 50bab3b2-f710-46ff-96cd-1ec4d4658529 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | f42506f7-896c-47a9-a4b1-ed72434d7aa0 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 58bff8bf-5a4e-4390-9c03-e266d31deb6b | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | daf579dc-91d1-4950-b637-c1a34f5542c5 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Sam's West, Inc. | 90c301ad-7bbd-4e21-8054-35596b208cd4 | 2019-11-21 | Warnings | WK2XYI10QM |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL | |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 72b32512-05c7-4113-b0cc-de9c97de2abb | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Bionpharma Inc. | d7d00fe3-c537-486e-8156-9b56b550bff5 | 2019-09-06 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Wal-Mart Stores, Inc | c100129d-3754-4d0e-b754-76440d55944a | 2019-08-23 | Warnings | WK2XYI10QM |
| Ibuprofen 200 | IBUPROFEN | WALGREEN COMPANY | 5fe0bdfa-1d5b-4657-a32b-f531b69bac0d | 2019-08-13 | Warnings | WK2XYI10QM |
| IBU | IBUPROFEN | Aphena Pharma Solutions - Tennessee, LLC | ffec2f44-1144-4729-b43a-1db40ea6a8d3 | 2019-05-15 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen mini | IBUPROFEN MINI | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 787cda64-c03e-462e-9590-6f04b6860610 | 2019-05-02 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC | b234d42e-1333-48a1-8565-35d9759e8085 | 2019-03-29 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.